tirzepatide peak sales Lilly Grows Revenue 41% in H1'25 as Hits USD 14.7b Overview of GLP-1s
Description
The SURMOUNT-1 clinical trial showed that participants on just 5 mg lost an average of 15% of their body weight over 72 weeks
Glycine adds a stabilizing effect but can increase viscosity slightly
The most common are 5mg/ml, 10mg/ml, and 20mg/ml
Tirzepatide (Mounjaro) is the first in its class peptide that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
If the cancellation policy is not clearly stated on the website, proceed with caution
